V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180005369 | 180003504 | null | null | null | null | 2016-12-22 | CARBOPLATIN + GEMCITABINE | null | null | CETUXIMAB + OXALIPLATIN + MDG | 101475349 |
| 180005449 | 180003505 | null | null | null | 2019-01-17 | 2019-01-23 | null | null | null | DINUTUXIMAB BETA | 100345088 |
| 180005473 | 180003506 | null | null | null | null | 2019-04-22 | CABOZANTINIB | null | null | TALIMOGENE LAHERPAREPVEC | 100748983 |
| 180005501 | 180003508 | null | null | null | 2018-07-21 | 2018-07-31 | null | null | null | ABEMACICLIB + FULVESTRANT | 100695740 |
| 180005621 | 180003509 | null | null | null | null | 2019-02-07 | FLUOROURACIL | null | null | NB HRNBL-1 BUMEL MAT | 100363941 |
| 180005697 | 180003510 | null | null | null | 2020-04-07 | 2021-01-11 | Paclitaxel 7 day | null | null | LENVATINIB | 101780093 |
| 180005766 | 180003512 | null | null | null | 2017-06-13 | 2017-10-23 | Rituximab | null | null | NB HRNBL-1 ISOTRETINOIN | 101797861 |
| 180005800 | 180003516 | null | null | null | null | 2018-05-25 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 101625425 |
| 180005817 | 180003518 | null | null | null | null | 2021-06-23 | CAPECITABINE + LOMUSTINE | null | null | TRETINOIN | 101415269 |
| 180005907 | 180003520 | null | null | null | null | 2019-02-08 | NB Low/Interm risk guidelines Carbo/Etop | null | null | CABOZANTINIB | 101101259 |
| 180006022 | 180003525 | null | null | null | null | 2021-01-23 | NB HRNBL-1 COJEC Ind COURSE C | null | null | NOT MATCHED | 100608661 |
| 180006051 | 180003526 | null | null | null | null | 2017-06-05 | NB HRNBL-1 BUMEL MAT | null | null | TIVOZANIB | 100981618 |
| 180006303 | 180003530 | null | null | null | null | 2018-02-19 | ALL UKALL2011 Consolidation A | null | null | LENVATINIB | 100648840 |
| 180006571 | 180003536 | null | null | null | 2018-11-06 | 2018-11-08 | CABOZANTINIB | null | null | CAPECITABINE + TEMOZOLOMIDE | 101626114 |
| 180006682 | 180003539 | 1.57 | null | null | null | 2020-06-25 | CABOZANTINIB | null | null | NB RELAPSED CYCLOPHOSPHAMIDE AND TOPOTECAN | 100826724 |
| 180006830 | 180003544 | null | null | null | null | 2017-10-14 | Letrozole + Palbociclib | null | null | CAPECITABINE + OXALIPLATIN | 101821960 |
| 180007391 | 180003556 | null | null | null | null | 2020-10-06 | Cisplatin | null | null | TRIAL | 100166188 |
| 180007658 | 180003559 | null | null | null | null | 2021-07-21 | GEMCITABINE | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 100708925 |
| 180008041 | 180003563 | null | null | null | 2022-04-12 | 2022-04-25 | null | null | null | FLUOROURACIL + IRINOTECAN | 100156298 |
| 180008049 | 180003564 | null | null | null | 2018-01-16 | 2019-01-03 | NB Rel CCLG guidelines Cyclo-Topotecan | null | null | VINBLASTINE | 101548929 |
| 180008070 | 180003566 | null | null | null | null | 2018-11-11 | null | null | null | CABOZANTINIB | 100807613 |
| 180008239 | 180003567 | null | null | null | 2016-04-26 | 2016-08-31 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | NIVOLUMAB | 100964595 |
| 180008397 | 180003572 | null | null | null | 2017-01-09 | 2017-01-21 | PEMBROLIZUMAB | null | null | GEFITINIB | 100905689 |
| 180008503 | 180003576 | null | null | null | null | 2022-02-07 | Cyclophosphamide + Topotecan | null | null | LENVATINIB | 100860189 |
| 180008645 | 180003580 | null | null | null | null | 2019-08-10 | LENVATINIB | null | null | LENVATINIB | 100416811 |
| 180008672 | 180003581 | null | null | null | null | 2021-09-18 | NB Relapsed CCLG guidelines TVD | null | null | CABOZANTINIB | 101096099 |
| 180009056 | 180003593 | null | null | null | null | 2015-01-25 | Folfirinox | null | null | LENVATINIB | 100060442 |
| 180009493 | 180003600 | 0.9 | null | null | null | 2021-01-20 | null | null | null | LENVATINIB | 100162052 |
| 180009719 | 180003605 | null | null | null | 2017-05-11 | 2018-01-11 | CABOZANTINIB | null | null | TEMOZOLOMIDE | 100657919 |
| 180009922 | 180003607 | null | null | null | null | 2016-07-20 | Cyclophosphamide + Topotecan | 02 | null | MITOTANE | 101050776 |
| 180010221 | 180003616 | null | null | null | 2016-06-21 | 2016-08-18 | NB HRNBL-1 Isotretinoin | null | null | ETOPOSIDE | 100590552 |
| 180010302 | 180003618 | 0 | null | null | null | 2020-07-09 | NB HRNBL-1 Isotretinoin | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101292168 |
| 180010319 | 180003619 | null | null | null | null | 2021-08-02 | Dinutuximab Beta | null | null | NB HRNBL-1 ISOTRETINOIN | 100947003 |
| 180010324 | 180003620 | null | null | null | 2018-04-28 | 2018-05-12 | NB 13 cis-RA (Isotretinoin) | null | null | PACLITAXEL | 100010791 |
| 180010672 | 180003629 | 0 | null | null | null | 2019-08-29 | CABOZANTINIB | null | null | NOT MATCHED | 100230100 |
| 180010875 | 180003633 | null | null | null | 2018-10-13 | 2018-10-19 | null | null | null | AFATINIB | 101719165 |
| 180011012 | 180003636 | 1.6 | null | null | null | 2016-11-13 | NB HRNBL-1 COJEC Ind COURSE C | null | null | TEMOZOLOMIDE | 101388485 |
| 180011465 | 180003644 | null | null | null | 2016-06-28 | 2016-09-24 | ETOPOSIDE | null | null | CABOZANTINIB | 101417709 |
| 180011471 | 180003645 | null | null | null | null | 2016-10-04 | BLEOMYCIN | null | null | IRINOTECAN + TEMOZOLOMIDE | 101802180 |
| 180011509 | 180003646 | null | null | null | 2016-08-12 | 2016-09-02 | null | null | null | DINUTUXIMAB BETA | 101057392 |
| 180011561 | 180003648 | null | null | null | 2022-01-07 | 2022-02-01 | NB HRNBL | null | null | NB HRNBL-1 ISOTRETINOIN | 101161065 |
| 180011605 | 180003649 | null | null | null | null | 2019-10-26 | Paclitaxel 7 day | null | null | CAPECITABINE | 101044554 |
| 180011624 | 180003650 | null | null | null | null | 2018-06-25 | Carboplatin + Paclitaxel (3 weekly) | null | null | GEMCITABINE + OXALIPLATIN | 100402036 |
| 180011774 | 180003651 | null | null | null | 2021-08-09 | 2021-08-20 | Paclitaxel 7 day | null | null | CISPLATIN + ETOPOSIDE | 101517461 |
| 180011831 | 180003653 | null | null | null | 2016-08-25 | 2016-08-26 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | NB HRNBL-1 ISOTRETINOIN | 101699307 |
| 180012053 | 180003657 | 0 | null | null | 2017-07-13 | 2017-07-15 | LENVATINIB | null | null | NB HRNBL-1 ISOTRETINOIN | 100533702 |
| 180012140 | 180003662 | null | null | null | null | 2020-01-16 | Docetaxel + Gemcitabine with GCSF | null | null | CARBOPLATIN + PACLITAXEL | 101195072 |
| 180012276 | 180003667 | null | null | null | 2022-02-21 | 2022-02-21 | CABOZANTINIB | null | null | CARBOPLATIN + GEMCITABINE | 101017820 |
| 180012367 | 180003668 | null | null | null | 2011-08-06 | 2012-06-19 | null | 01 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100785100 |
| 180012498 | 180003669 | null | null | null | 2019-03-08 | 2019-03-13 | CAPECITABINE + OXALIPLATIN | null | null | MITOTANE | 100382881 |